PubMed=20594083; DOI=10.2460/ajvr.71.7.799
McMahon M.B., Bear M.D., Kulp S.K., Pennell M.L., London C.A.
Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
Am. J. Vet. Res. 71:799-808(2010)

PubMed=21621658; DOI=10.1016/j.bone.2011.05.008; PMCID=PMC3143255
Scott M.C., Sarver A.L., Gavin K.J., Thayanithy V., Getzy D.M., Newman R.A., Cutter G.R., Lindblad-Toh K., Kisseberth W.C., Hunter L.E., Subramanian S., Breen M., Modiano J.F.
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach.
Bone 49:356-367(2011)

PubMed=23311495; DOI=10.1186/1750-1172-8-7; PMCID=PMC3566973
Sarver A.L., Thayanithy V., Scott M.C., Cleton-Jansen A.-M., Hogendoorn P.C.W., Modiano J.F., Subramanian S.
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Orphanet J. Rare Dis. 8:7.1-7.11(2013)